NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for acute lymphocytic leukemia


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alexion Reports Third Quarter 2009 Results
2009 NOV 2 ... a second rare kidney disorder, dense deposit disease, treated with Soliris. Transplant: Acute Humoral Kidney Rejection (AHR) Soliris is also being investigated for the prevention of ... and dosing in a clinical study of its anti-CD200 antibody in patients with chronic lymphocytic leukemia. Early pharmacodynamic and biologic data suggest drug activity in this patient ...
Subject: Alexion Pharmaceuticals, Inc.
Price: $3.00
*
American Cancer Society report describes unique cancer profile of Hispanic/Latino Americans
2009 SEP 28 ... have higher rates of cancers of the stomach, cervix, liver, and gallbladder, and of acute lymphocytic leukemia; have a later stage of diagnosis for many cancers, including breast and ...
Subject: American Cancer Society
View Free
Daily News
Article
Boston University reports research in leukemia epidemiology
2009 OCT 5 ... cellular telephone use and other factors to the etiology of the disease; 180 cases (87 acute myeloblastic leukemia, 40 acute lymphoblastic leukemia, 44 chronic myelogenous leukemia, ... 40 acute lymphoblastic leukemia, 44 chronic myelogenous leukemia, eight chronic lymphocytic leukemia, one unclassified acute leukemia) were compared with 756 age-and sex-matched ...
Subject: Leukemia Epidemiology
Price: $3.00
*
Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
2009 NOV 2 ... 5. Chromosome Analysis a. Chronic Myelogenous Leukemia (CML) b. Acute Myeloid Leukemia (AML) c. Acute Lymphoblastic Leukemia (ALL) d. Malignant Lymphomas ... Leukemia (ALL) d. Malignant Lymphomas Lymphoid Malignancies e. Chronic Lymphocytic Leukemia (CLL) f. Solid Cancers g. Chromosomal Translocation and Oncogenes ...
Subject: Research and Markets
Price: $3.00
*
Celgene Reports Record Third Quarter 2009 Operating and Financial Results
2009 NOV 2 ... (MDS) VIDAZA Now Listed By NCCN As Low Intensity Treatment Option For Patients With Acute Myeloid Leukemia Initiated Phase II Trial Of ACE-011 For Treatment Of Chemotherapy ... Including Novel Combinations In Multiple Patient Segments Advance REVLIMID Chronic Lymphocytic Leukemia (CLL) Initiative Through More Than 40 Clinical Trials Worldwide Complete ...
Subject: Celgene Corporation
Price: $3.00
*
Genzyme Reports Third-Quarter Financial Results
2009 NOV 2 ... the FDA to discuss a path forward for the potential use of Clolar in adult patients with acute myeloid leukemia, following the receipt of a complete response letter regarding the ... 3 trial of Campath's use in combination with Fludara in relapsed or refractory chronic lymphocytic leukemia patients, which recently met its primary endpoint. There will be presentations ...
Subject: Genzyme Corp.
Price: $3.00
*
Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer
2009 NOV 23 ... Holiday campaign, LLS is featuring the story of Matthew Donnelly, who was diagnosed with acute lymphocytic leukemia when he was 2 1/2 years old. Matthew and his family participated in both the spring and ...
Subject: Blood Cancer
Price: $3.00
*
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st American Society of Hematology Meeting
2009 NOV 23 ... such as multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia and myelodysplastic syndromes. Keywords: , Health, ...
Subject: Celgene Corporation
Price: $3.00
*
New Leukemia Report: Acute Lymphoblastic, Chronic Lymphocytic, Myelogenous, Acute Myelogenous and Hairy Cell Leukemia Therapy Area Pipeline Report
2009 SEP 7 ... has announced the addition of the "Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic ...
Subject: Research and Markets
Price: $3.00
*
New lower back pain study findings recently were reported by researchers at Peking University
2009 AUG 31 ... adipose sarcoma, advanced gastric carcinoma, ovarian papillary epithelioma, acute lymphocytic leukemia), six benign tumors (two parathyroid adenoma with hyperparathyroidism, one intraspinal ...
Subject: Lower Back Pain
Price: $3.00
*
New non-hodgkin lymphoma research from University of Rochester outlined
2009 OCT 12 ... Keywords: United States, Box, AIDS, Acquired Immunodeficiency Syndrome, Acute Lymphocytic Leukemia, Burkitt Lymphoma, Chemotherapy, Clinical Trial Research, Drug Therapy, HIV, Hematology, ...
Subject: Non-Hodgkin Lymphoma
Price: $3.00
*
New stem cell research from National Institutes of Health outlined
2009 NOV 2 ... cell miR, miR-155, were up-regulated in G-CSF-mobilized CD34(+) cells. A pre-B-cell acute lymphocytic leukemia miR, miR-143-3p, and a T-cell miR, miR-143-5p, were up-regulated in plerixafor plus ...
Subject: Stem Cell Research
Price: $3.00
*
Nine-Year-Old "Chef" Jack Witherspoon Teams with Beckstrand Cancer Foundation in Support of Pediatric Cancer Patients
2009 SEP 14 ... to more children in need." At the age of two, Jack was diagnosed with Acute Lymphocytic Leukemia (ALL). He began a course of chemotherapy and steroid treatment that lasted more than ...
Subject: Beckstrand Cancer Foundation
Price: $3.00
*
Research conducted at University Medical Center has updated our knowledge about life sciences
2009 OCT 12 ... however, the exact underlying mechanism is not known. We used two variants of a mouse acute lymphocytic leukemia cell line (L1210), a suspension (L1210-S) and an adherent (L1210-A) variant that were ...
Subject: Life Sciences
Price: $3.00
*
Research reports on apoptosis from University of Texas provide new insights
2009 NOV 2 ... of oxidative stress and loss of glutathione in ABT-737-induced apoptosis. Jurkat human acute lymphocytic leukemia cells and HeLa cells transfected with a tet-regulated Bcl-2 expression system were ...
Subject: Apoptosis
Price: $3.00
*
Studies from Harvard University, Medical Department in the area of leukemia described
2009 OCT 5 ... essential role in the pathogenesis of chronic myeloid leukemia (CML) and some cases of acute lymphocytic leukemia (ALL). Although ABL kinase inhibitors have shown great promise in the treatment of CML, ...
Subject: Leukemia
Price: $3.00
*
Studies from P.M. Herst and colleagues reveal new findings on cancer
2009 AUG 31 ... that leukemic blasts from patients with primary acute myeloid leukemia (n=22) and acute lymphocytic leukemia (n=8) were sensitive to phenoxodiol. The lymphocytic leukemic blasts were more sensitive ...
Subject: Cancer
Price: $3.00
*
Study data from Wuhan University provide new insights into leukemia
2009 SEP 14 ... 9 (CCR9) was highly expressed on CD4(+) T cells from patients with T-cell lineage acute lymphocytic leukemia (T-ALL) and mediated leukemia cell infiltration and metastasis. Combined use of ...
Subject: Leukemia
Price: $3.00
*
Study results from Ohio State University provide new insights into chronic lymphocytic leukemia
2009 NOV 9 ... target drug concentrations in vivo. In phase I testing, this dosing schedule resulted in acute tumor lysis syndrome (TLS) as the doselimiting toxicity. With the implementation of a ... According to recent research from the United States, "With chronic lymphocytic leukemia (CLL) with high-risk cytogenetic features such as del(17p13) have limited ...
Subject: Chronic Lymphocytic Leukemia
Price: $3.00
*
The Leukemia & Lymphoma Society to Fund Research Focused on Long-Term and Late Effects of Cancer Treatment
2009 SEP 28 ... and clinical trials enabled survival rates to reach nearly 90% for children with acute lymphocytic leukemia. But then the medical and research community recognized that the serious late effects ...
Subject: Leukemia
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login